- Home
- Publications
- Publication Search
- Publication Details
Title
New antibiotics for bad bugs: where are we?
Authors
Keywords
New antibiotics, Resistance, Bacteria, FDA, EMA
Journal
Annals of Clinical Microbiology and Antimicrobials
Volume 12, Issue 1, Pages 22
Publisher
Springer Nature
Online
2013-08-29
DOI
10.1186/1476-0711-12-22
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New β-lactam-β-lactamase inhibitor combinations in clinical development
- (2013) David M. Shlaes Annals of the New York Academy of Sciences
- Phase II Clinical Study of BC-3781, a Pleuromutilin Antibiotic, in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections
- (2013) W. T. Prince et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human Simulated Studies of Aztreonam and Aztreonam-Avibactam To Evaluate Activity against Challenging Gram-Negative Organisms, Including Metallo-β-Lactamase Producers
- (2013) Jared L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011)
- (2013) Ronald N. Jones et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Aminoglycoside therapy in infectious diseases
- (2013) Panagiotis Poulikakos et al. EXPERT OPINION ON PHARMACOTHERAPY
- Clinical relevance of the ESKAPE pathogens
- (2013) Jack N Pendleton et al. Expert Review of Anti-Infective Therapy
- Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections
- (2013) Philippe Prokocimer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli
- (2013) B. Hofer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenems
- (2013) Dominique Breilh et al. JOURNAL OF CHEMOTHERAPY
- Pharmacotherapy for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
- (2012) Marisel Segarra-Newnham et al. ANNALS OF PHARMACOTHERAPY
- Efficacy of Ceftobiprole Medocaril against Enterococcus faecalis in a Murine Urinary Tract Infection Model
- (2012) Kavindra V. Singh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vancomycin Tolerance in Methicillin-Resistant Staphylococcus aureus: Influence of Vancomycin, Daptomycin, and Telavancin on Differential Resistance Gene Expression
- (2012) Warren E. Rose et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Worldwide Appraisal and Update (2010) of Telavancin Activity Tested against a Collection of Gram-Positive Clinical Pathogens from Five Continents
- (2012) Rodrigo E. Mendes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftobiprole EfficacyIn Vitroagainst Panton-Valentine Leukocidin Production andIn Vivoagainst Community-Associated Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rabbits
- (2012) Azzam Saleh-Mghir et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of the Investigational Pleuromutilin Compound BC-3781 Tested against Gram-Positive Organisms Commonly Associated with Acute Bacterial Skin and Skin Structure Infections
- (2012) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria
- (2012) Elizabeth B. Hirsch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroAntibacterial Activity of the Ceftazidime-Avibactam (NXL104) Combination against Pseudomonas aeruginosa Clinical Isolates
- (2012) Premavathy Levasseur et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic
- (2012) Trudy H. Grossman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin: A New Opportunity for Outpatient Therapy of Serious Infections
- (2012) A. Tice CLINICAL INFECTIOUS DISEASES
- Oritavancin: Mechanism of Action
- (2012) George G. Zhanel et al. CLINICAL INFECTIOUS DISEASES
- Ceftaroline Fosamil: A Cephalosporin With Activity Against Methicillin-Resistant Staphylococcus Aureus
- (2012) Henry Poon et al. CLINICAL THERAPEUTICS
- In vitro activities of ceftobiprole, dalbavancin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus blood isolates: stratified analysis by vancomycin MIC
- (2012) Yong Pil Chong et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Activity of JNJ-Q2, a novel fluoroquinolone, tested against Neisseria gonorrhoeae, including ciprofloxacin-resistant strains
- (2012) Douglas J. Biedenbach et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
- (2012) George G Zhanel et al. Expert Review of Anti-Infective Therapy
- Activity of ceftobiprole against Streptococcus pneumoniae isolates exhibiting high-level resistance to ceftriaxone
- (2012) Todd A. Davies et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation
- (2012) Susan C. Nicholson et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)
- (2012) H. S. Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization
- (2012) J. M. Remy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii
- (2012) P. G. Higgins et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of Plazomicin (ACHN-490) against MDR clinical isolates ofKlebsiella pneumoniae, Escherichia coli, andEnterobacterspp. from Athens, Greece
- (2012) Irene Galani et al. JOURNAL OF CHEMOTHERAPY
- Efficacy and Safety of Telavancin in Clinical Trials: A Systematic Review and Meta-Analysis
- (2012) Konstantinos A. Polyzos et al. PLoS One
- Avibactam is a covalent, reversible, non- -lactam -lactamase inhibitor
- (2012) D. E. Ehmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin
- (2012) Praveena Marconescu et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- The oxazolidinones: past, present, and future
- (2011) Karen Joy Shaw et al. Annals of the New York Academy of Sciences
- In VitroAntimicrobial Activity of Razupenem (SMP-601, PTZ601) against Anaerobic Bacteria
- (2011) Chau Minh Tran et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Razupenem (PZ601) Studied in anIn VitroPharmacokinetic Model of Infection
- (2011) Alasdair P. MacGowan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of CXA-101, a Novel Cephalosporin Tested in Combination with Tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis Strains Having Various Resistance Phenotypes
- (2011) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Ceftaroline against Gram-Positive and Gram-Negative Pathogens Isolated from Patients in Canadian Hospitals in 2009
- (2011) James A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of the Efficacy and Safety of Oritavancin Front-Loaded Dosing Regimens to Daily Dosing: an Analysis of the SIMPLIFI Trial
- (2011) Lala M. Dunbar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenems: Past, Present, and Future
- (2011) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Can We Really Use ss-Lactam/ss-Lactam Inhibitor Combinations for the Treatment of Infections Caused by Extended-Spectrum ss-Lactamase-Producing Bacteria?
- (2011) F. Perez et al. CLINICAL INFECTIOUS DISEASES
- In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007–2009 study
- (2011) Andrew Walkty et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007–2009 study
- (2011) James A. Karlowsky et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent
- (2011) Xiao-Yi Xiao et al. JOURNAL OF MEDICINAL CHEMISTRY
- The crisis of no new antibiotics—what is the way forward?
- (2011) Laura JV Piddock LANCET INFECTIOUS DISEASES
- Activity of Polymyxin B and the Novel Polymyxin Analogue CB-182,804 Against Contemporary Gram-Negative Pathogens in New York City
- (2011) John Quale et al. Microbial Drug Resistance
- Doripenem: A new carbapenem antibiotic
- (2010) E. B. Chahine et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- In Vitro Potentiation of Carbapenems with ME1071, a Novel Metallo- -Lactamase Inhibitor, against Metallo- -Lactamase- Producing Pseudomonas aeruginosa Clinical Isolates
- (2010) Y. Ishii et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Pharmacodynamic Activity of Tomopenem (formerly CS-023) against Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus in a Murine Thigh Infection Model
- (2010) K. Sugihara et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Activities of Nemonoxacin (TG-873870), a Novel Nonfluorinated Quinolone, and Other Quinolones against Clinical Isolates
- (2010) T.-L. Lauderdale et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of a New Cephalosporin, CXA-101 (FR264205), against -Lactam-Resistant Pseudomonas aeruginosa Mutants Selected In Vitro and after Antipseudomonal Treatment of Intensive Care Unit Patients
- (2010) B. Moya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli
- (2010) M. G. P. Page et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Multicenter, Randomized Controlled Clinical Study on Biapenem and Imipenem/Cilastatin Injection in the Treatment of Respiratory and Urinary Tract Infections
- (2010) Bei Jia et al. CHEMOTHERAPY
- Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection
- (2010) G. Ralph Corey et al. CLINICAL INFECTIOUS DISEASES
- Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled‐Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community‐Acquired Pneumonia
- (2010) Thomas M. File et al. CLINICAL INFECTIOUS DISEASES
- Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens
- (2010) E. Rubinstein et al. CLINICAL INFECTIOUS DISEASES
- Besifloxacin: A topical fluoroquinolone for the treatment of bacterial conjunctivitis
- (2010) Mei H. Chang et al. CLINICAL THERAPEUTICS
- Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies
- (2010) Rebecca A. Keel et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- New Lipoglycopeptides
- (2010) George G. Zhanel et al. DRUGS
- In vivo antibacterial activity of nemonoxacin, a novel non-fluorinated quinolone
- (2010) C.-R. Li et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Hydrolysis and Inhibition Profiles of -Lactamases from Molecular Classes A to D with Doripenem, Imipenem, and Meropenem
- (2009) A. M. Queenan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Nemonoxacin, a Novel Nonfluorinated Quinolone, against 2,440 Clinical Isolates
- (2009) H. J. Adam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intravenous Doripenem at 500 Milligrams versus Levofloxacin at 250 Milligrams, with an Option To Switch to Oral Therapy, for Treatment of Complicated Lower Urinary Tract Infection and Pyelonephritis
- (2009) K. G. Naber et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Doripenem
- (2009) David L. Paterson et al. CLINICAL INFECTIOUS DISEASES
- Doripenem monohydrate, a broad-spectrum carbapenem antibiotic
- (2009) S.James Matthews et al. CLINICAL THERAPEUTICS
- Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study*
- (2009) Jean Chastre et al. CRITICAL CARE MEDICINE
- Beta-lactams and Beta-lactamase-inhibitors in current- or potential-clinical practice: A comprehensive update
- (2009) M. Shahid et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Current Status of Newer Carbapenems
- (2009) Matteo Bassetti et al. CURRENT MEDICINAL CHEMISTRY
- Population Pharmacokinetics of Tebipenem Pivoxil (ME1211), a Novel Oral Carbapenem Antibiotic, in Pediatric Patients with Otolaryngological Infection or Pneumonia
- (2009) Nobuo Sato et al. Drug Metabolism and Pharmacokinetics
- In Vitro Activities of the Rx-01 Oxazolidinones against Hospital and Community Pathogens
- (2008) L. Lawrence et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States
- (2008) Y. Ge et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: A phase III, prospective, multicenter, randomized, double-blind, noninferiority study
- (2008) Christopher Lucasti et al. CLINICAL THERAPEUTICS
- Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study
- (2008) Álvaro Réa-Neto et al. CURRENT MEDICAL RESEARCH AND OPINION
- Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections
- (2008) George G Zhanel et al. Expert Review of Anti-Infective Therapy
- The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
- (2007) B. Spellberg et al. CLINICAL INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started